Wednesday September 15, 2010

REVERSED

1600 Biotechnology and Organic Chemistry
Ex Parte Dreyer 10/885,422 PRATS 112(1)/103(a) ALLERGAN, INC. Examiner Name: FAY, ZOHREH A

However, “patents are not barred just because it was obvious ‘to explore a new technology or general approach that seemed to be a promising field of experimentation, where the prior art gave only general guidance as to the particular form of the claimed invention or how to achieve it.’” Procter & Gamble Co. v. Teva Pharmaceuticals USA, Inc., 566 F.3d 989, 997 (Fed. Cir. 2009) (quoting In re O’Farrell, 853 F.2d, at 903).

O’Farrell, In re, 853 F.2d 894, 7 USPQ2d 1673 (Fed. Cir. 1988) . . 2143.01, 2143.02, 2144.08, 2145

Ex Parte Rasochova et al 11/069,601 McCOLLUM 103(a) WILSON, SONSINI, GOODRICH & ROSATI Examiner Name: WORLEY, CATHY KINGDON

Ex Parte Scavone et al 11/712,771 WALSH 103(a) THE PROCTER & GAMBLE COMPANY Examiner Name: KASSA, TIGABU

2100 Computer Architecture and Software
Ex Parte Conner 11/252,341 COURTENAY 102(a)/103(a) HOGAN LOVELLS US LLP Examiner Name: MYERS, PAUL R

2400 Networking, Mulitplexing, Cable, and Security
Ex Parte McGee et al 10/043,355 COURTENAY 103(a) RSW IP Law IBM CORPORATION Examiner Name: NGUYEN, THANH T

Ex Parte Proidl 09/954,654 HOFF 102(e)/103(a) PHILIPS INTELLECTUAL PROPERTY & STANDARDS Examiner Name: TANG, KAREN C

Ex Parte Saxena et al 09/987,955 COURTENAY 103(a) DAVIS WRIGHT TREMAINE, LLP/Seattle Examiner Name: TRAN, NGHI V

3600 Transportation, Construction, Electronic Commerce, Agriculture, National Security, and License & Review
Ex Parte Suzuki 10/301,608 FETTING 102(e)/103(a) 37 C.F.R. 5 41.50(b) SUGHRUE MION, PLLC Examiner Name: LASTRA, DANIEL

AFFIRMED-IN-PART

2400 Networking, Mulitplexing, Cable, and Security
Ex Parte Bonnell et al 10/152,509 JEFFERY 112(1)/102(a)/103(a)/101 103(a) 37 C.F.R. § 41.50(b) WONG, CABELLO, LUTSCH, RUTHERFORD & BRUCCULERI, L.L.P. Examiner Name: SHAW, PELING ANDY

2600 Communications
Ex Parte Giesberts et al 10/949,444 HOFF 102(e)/103(a) RYAN, MASON & LEWIS, LLP Examiner Name: HSIEH, PING Y

3700 Mechanical Engineering, Manufacturing, and Products & Design
Ex Parte Wilson et al 11/062,970 LEE 103(a) Siemens Corporation Examiner Name: SUNG, GERALD LUTHER

VACATED

1600 Biotechnology and Organic Chemistry
Ex Parte Rice 11/367,500 FREDMAN 103(a)/103(a) 37 C.F.R. § 41.50(b) INGRID MCTAGGART Examiner Name: CLAYTOR, DEIRDRE RENEE

REEXAMINATION

EXAMINER AFFIRMED

3900 Central Reexamination Unit (CRU) Original Art Unit 2771
Ex parte IO RESEARCH PTY. LIMITED, Appellant and Patent Owner 90/008,058 6,076,094 TURNER 102(b)/102(e)/103(a) PATENT OWNER: GREENBLUM & BERNSTEIN, P.L.C. THIRD PARTY REQUESTER: Richard Kim MORRISON & FOESTER LLP Examiner Name: CHOI, WOO H original app Examiner Name: HO, RUAY L

“It is also an elementary principle of patent law that when, as by recitation of ranges, or otherwise, a claim covers several compositions, the claim is “anticipated” if one of them is in the prior art.” Titanium Metals Corp. of Am. v. Banner, 778 F.2d. 775, 782 (Fed. Cir. 1985). While the referenced case is directed to chemical compositions, we find that it is equally applicable to claims which provide limitations in the alternative. See Also Blackboard, Inc. v. Desire2Learn, Inc., 574 F.3d 1371, 1377-1381 (Fed. Cir. 2009)( If a limitation is optional, then prior art without the optional limitation can anticipate).

Titanium Metals Corp. of America v. Banner, 778 F.2d 775, 227 USPQ 773 (Fed. Cir. 1985). . . . . . . . . . . . . . 2112.01, 2131.01, 2131.03, 2144.05

NEW

REVERSED

Ex Parte Miyazawa et al

AFFIRMED

Ex Parte Ajmera et al
Ex Parte Antonini
Ex Parte Bridgewater et al
Ex Parte Camillocci et al
Ex Parte Capotosto et al
Ex Parte Cripe
Ex Parte Goldstein
Ex Parte Griffin et al
Ex Parte Manion et al
Ex Parte McNulty et al
Ex Parte Pathiyal
Ex Parte Woods et al

REHEARING

Ex Parte Feist et al